A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents.

Trial Profile

A Worldwide, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study Clinical Trial to Evaluate the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Rizatriptan (Primary)
  • Indications Migraine with aura; Migraine without aura
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 15 Mar 2013 New source identified and integrated (Clinical Trials Registry - India; CTRI2010-091-000407)
    • 19 Oct 2012 Planned number of patients changed from 1240 to 1340.
    • 30 Jun 2012 Inclusion and exclusion criteria amended from EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top